Data / Form D filings / Moderna LLC
Moderna LLC: Form D filings
Moderna LLC, a pharmaceuticals company in Cambridge, MA, filed 3 Form D notices with the SEC between 2013 and 2015. The latest, on January 5, 2015, reports $446.1 million sold of a $502.2 million offering to 43 investors.
Find out what Moderna LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 TECH SQUARE, Cambridge, MA, 02139
- Phone
- (617) 714-6500
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1592247
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 5, 2015 | New notice | $502,168,634 | $446,069,409 | $56,099,225 | 43 | Dec 19, 2014 | sec.gov |
| Jan 23, 2014 | Amendment | $135,000,044 | $135,000,044 | $0 | 40 | Nov 6, 2013 | sec.gov |
| Nov 20, 2013 | New notice | $110,000,026 | $110,000,026 | $0 | 39 | Nov 6, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephane Bancel | Executive Officer, Director | |
| Lorence Kim | Executive Officer | |
| James Kasinger | Executive Officer | |
| Noubar Afeyan | Director | |
| Lee Babiss | Director | |
| Robert Carpenter | Director | |
| Theo Melas-Kyriazi | Director | |
| Robert Langer | Director | |
| Peter Hutt | Director | |
| John Mendlein | Director | |
| Henri Termeer | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- BridgeHealth Pharmaceuticals, Inc. $3.5 million · Nov 5, 2026
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jan 5, 2015 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Moderna LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.